Clinical Trials Browser

Phase 2 × Neoplasms, Plasma Cell × oblimersen × Clear all

NCT00049374 2019-10-17

Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell